Journey Medical (DERM) Competitors $7.47 +0.39 (+5.51%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$7.49 +0.02 (+0.27%) As of 08/22/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DERM vs. FBIO, ABUS, KALV, KURA, BCAX, TSHA, VIR, TERN, RLAY, and SIGAShould you be buying Journey Medical stock or one of its competitors? The main competitors of Journey Medical include Fortress Biotech (FBIO), Arbutus Biopharma (ABUS), KalVista Pharmaceuticals (KALV), Kura Oncology (KURA), Bicara Therapeutics (BCAX), Taysha Gene Therapies (TSHA), Vir Biotechnology (VIR), Terns Pharmaceuticals (TERN), Relay Therapeutics (RLAY), and Siga Technologies (SIGA). These companies are all part of the "medical" sector. Journey Medical vs. Its Competitors Fortress Biotech Arbutus Biopharma KalVista Pharmaceuticals Kura Oncology Bicara Therapeutics Taysha Gene Therapies Vir Biotechnology Terns Pharmaceuticals Relay Therapeutics Siga Technologies Journey Medical (NASDAQ:DERM) and Fortress Biotech (NASDAQ:FBIO) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, media sentiment, valuation, dividends, earnings and profitability. Which has more risk & volatility, DERM or FBIO? Journey Medical has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. Comparatively, Fortress Biotech has a beta of 1.76, meaning that its stock price is 76% more volatile than the S&P 500. Does the media favor DERM or FBIO? In the previous week, Fortress Biotech had 4 more articles in the media than Journey Medical. MarketBeat recorded 17 mentions for Fortress Biotech and 13 mentions for Journey Medical. Fortress Biotech's average media sentiment score of 0.30 beat Journey Medical's score of 0.16 indicating that Fortress Biotech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Journey Medical 4 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Fortress Biotech 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Do institutionals & insiders have more ownership in DERM or FBIO? 7.3% of Journey Medical shares are held by institutional investors. Comparatively, 96.5% of Fortress Biotech shares are held by institutional investors. 15.0% of Journey Medical shares are held by insiders. Comparatively, 27.9% of Fortress Biotech shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is DERM or FBIO more profitable? Journey Medical has a net margin of -15.49% compared to Fortress Biotech's net margin of -24.84%. Journey Medical's return on equity of -48.69% beat Fortress Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Journey Medical-15.49% -48.69% -11.26% Fortress Biotech -24.84%-301.81%-27.48% Do analysts recommend DERM or FBIO? Journey Medical presently has a consensus price target of $11.75, suggesting a potential upside of 57.30%. Fortress Biotech has a consensus price target of $16.50, suggesting a potential upside of 626.87%. Given Fortress Biotech's stronger consensus rating and higher possible upside, analysts clearly believe Fortress Biotech is more favorable than Journey Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Journey Medical 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33Fortress Biotech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings and valuation, DERM or FBIO? Journey Medical has higher earnings, but lower revenue than Fortress Biotech. Journey Medical is trading at a lower price-to-earnings ratio than Fortress Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJourney Medical$56.13M3.10-$14.67M-$0.38-19.66Fortress Biotech$57.67M1.17-$46M-$1.05-2.16 SummaryFortress Biotech beats Journey Medical on 9 of the 15 factors compared between the two stocks. Get Journey Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DERM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DERM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DERM vs. The Competition Export to ExcelMetricJourney MedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$164.93M$2.54B$5.75B$9.62BDividend YieldN/A1.57%4.40%4.10%P/E Ratio-19.6622.9131.3026.05Price / Sales3.10554.08432.98193.75Price / CashN/A180.4637.7358.48Price / Book9.005.939.536.61Net Income-$14.67M$31.83M$3.26B$265.65M7 Day Performance7.48%1.89%2.13%2.02%1 Month Performance1.08%1.33%2.80%-0.31%1 Year Performance54.66%8.84%30.68%19.06% Journey Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DERMJourney Medical1.6232 of 5 stars$7.47+5.5%$11.75+57.3%+65.6%$164.93M$56.13M-19.6690FBIOFortress Biotech2.7933 of 5 stars$2.25+6.1%$21.00+833.3%+8.6%$62.69M$57.78M-2.14170News CoverageAnalyst ForecastAnalyst RevisionHigh Trading VolumeABUSArbutus Biopharma2.736 of 5 stars$3.38+0.3%$5.50+62.7%-5.8%$645.07M$6.17M-11.6690News CoverageKALVKalVista Pharmaceuticals4.0138 of 5 stars$13.34+3.6%$26.29+97.0%+8.0%$643.41MN/A-3.62100KURAKura Oncology3.9439 of 5 stars$7.48+1.9%$24.10+222.2%-61.2%$637.09M$53.88M-3.31130BCAXBicara Therapeutics1.6238 of 5 stars$11.47-1.5%$31.86+177.8%N/A$635.11MN/A-3.6232Analyst ForecastTSHATaysha Gene Therapies3.3992 of 5 stars$2.93-0.3%$8.29+182.8%+33.9%$631.10M$8.33M-8.62180VIRVir Biotechnology3.4197 of 5 stars$4.48-0.9%$30.25+575.2%-45.0%$627.90M$74.21M-1.12580Positive NewsTERNTerns Pharmaceuticals3.7615 of 5 stars$6.76-4.1%$15.63+131.1%-11.9%$616.95MN/A-6.5040RLAYRelay Therapeutics1.8228 of 5 stars$3.47-2.0%$17.25+397.1%-46.8%$610.34M$10.01M-1.78330SIGASiga Technologies2.0758 of 5 stars$8.92+4.9%N/A-2.2%$608.65M$138.72M7.8940Options Volume Related Companies and Tools Related Companies Fortress Biotech Competitors Arbutus Biopharma Competitors KalVista Pharmaceuticals Competitors Kura Oncology Competitors Bicara Therapeutics Competitors Taysha Gene Therapies Competitors Vir Biotechnology Competitors Terns Pharmaceuticals Competitors Relay Therapeutics Competitors Siga Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DERM) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access